Construction of P3 phase ii expansion of the existing P3 biopharma production facility which includes the construction of a circa 2,155sq. M, two-storey biopharma production facility to a maximum height of circa 14. 9m to be located to the south of the existing p3 building; single-storey administration extension of circa 210sq. M to a maximum height of 4m to the north of the existing p3 building and internal modifications to the existing P3 building in addition to all associated site works including delivery area; courier pick up/drop off area with 5 parking spaces (including 1 accessible parking space and 1 e-car space); extension to existing external utility yard (circa 485sq. M) for 3 heat pumps and other ancillary equipment; new internal site circulation road and re-alignment of existing circulation road; 48 additional car parking spaces (including 3 accessible parking spaces and 5 e-car spaces); 24 covered bicycle stands, hard and soft landscaping and external lighting; there wiill be temporary site entrance and associated temporary access road located to the south east of the site during the construction phase all on 3.68 Hectare application site located within the Takeda Ireland facility at Grange Castle Business Park; an EIAR (Environmental Impact Assessment Report) is submitted with the application and relates to development comprising of an activity which requires and Industrial Emissions Licence in accordance with the First Schedule of the EPA Act 1992 as amended.
To find out more details on this Factory Development in Dublin Applied for on 2020-06-19 take the free trial here.
